Aditxt

-$0.27 (-14.84%) Today
+$0.02 (+1.29%) As of 9:42 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.

About ADTX

Aditxt, Inc. engages in the development of biotechnologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. It has a worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue.

CEO
Amro Albanna
Employees
43
Headquarters
Mountain View, California
Founded
2017

ADTX Key Statistics

Market Cap
31.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
12.80M
High Today
$1.60
Low Today
$1.51
Open Price
$1.52
Volume
6.37M
52 Week High
$6.73
52 Week Low
$1.51

ADTX Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure